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PREOPERATIVE AND INTRAOPERATIVE PREDICTORS OF SAPHENOUS METABOLIC AND FUNCTIONAL FATE OF VIABLE 
VEIN GRAFT OCCLUSION AFTER CORONARY BYPASS SURGERY MYOCARDIUM BY PETEARLY AFIER ACUTE INFARCTION 
, Gerald Porenta, Richard Bnmken, Robert Bennet, 
Jan Till&h, Michael Phelps, Heinrich Schelbert, UCLA School of 
Medicine, Los Angeles, CA, U.S.A. 
G.V.R.R. Sharma, Gulshan Sethi, Tom Horitz, Diane Lapsley, 
Shukri Khuri, William Henderson, Jack Copeland and Steve 
Goldman. From the VAX, West Roxbury and Harvard Medical 
School, Boston, HA for the Veterans Administration 
Cooperative Study (#20?) Group. 
In a prospective, randomized study designed to evaluate 
the efficacy of antiplatelet agents in the prevention of 
eaohenous vein graft occlusion (SVGO) after coronary by- 
paks surgery in-502 patients (1618 grafts), significant 
preoperative and intraoperative predictors of SVGO were: 
Predictor SVGO at 1 yr P-value 
Pre-operat ive 
Prior MI No 97/654 ( 14.8X) 0.04 
Yes 188/958 (19.6%) 
Choleatcrol t < 225 139/874 (15.9%) 0.06 
-7 225 131/644 (20.3%) 
HDL t > 30 104/712 (14.6%) 0.04 
< 30 M/399 (21.3%) 
Diameter of 79/545 (14.5%) 0.02 
Artery 205/1069 (19.2%) 
Intra-operative 
Artery 
Bypassed i 
LAD 791652 (12.1%) 0.0001 
RCA, Cx 207/966 (21.4X) 
Condition of 
t 
Normal 128/844 (15.2X) 0.01 
Artery SC lerosed 1531762 (20.1%) 
Vein Graft 
i 
No 184/1181 (15.6%) 0.003 
Too Thick/Thin Yee 99/426 (24.51) 
Prererv ing i Blood 28/222 (12.6X) 0.06 
Solution I Saline 258/1396 (18.5X) 
Cone lus ions : Patients at high risk for SVGO can be pro- 
aDectively identified; appropriate medical therapy and 
r&ice1 keasures rhoild-be employed to reduce Sib. 
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Viability Studies Using PET 
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ANGINA PECTORIS PATIENTS WITH NORMAL 
CORONARY ANGIOGRAMS, ABNORMAL MYOCARDIAL 
FATTY ACID METABOLISM EVALUATED BY POSITRON 
EMISSION TOMOGRAPHY AND LOW ENERGY 
CHARGE. A NEW SYNDROME? 
Bo Lagergvist, Gunnar Ronquist, Per Ham@, 
Bengt Lgngstim, University Hospital. University of Uppsala, 
Sweden. 
Some patients with angina pectoris have normal coronary angiograms 
despite perfusion defects on myocardial Tl-201 perfusion scintigram. 
These patients also often complain of excessive fatigue. In order to 
show ischemic metabolism in areas of perfusion defects 11-C palmitate 
turnover was measund with PET. The energy status of the myocardial 
and skeletal muscle biopsies was analyzed. 
Material and methods:Biopsies were taken from heart and m.triceps 
surae in 7 pats.Encrgy charge=EC=(ATP+l/ATP+ADP+AMP) 
and lactate were measured in the resting state. 11-C pahnitate activity 
was followed in the PET camera before and after submaximal exercise 
in four patients. Results: In the resting state no difference in palrritate 
metabolism was seen when hypoperfused areas were compared to well 
perfused myocardium. After exercise pahnitate metabolism decreased in 
all areas. EC at rest in m 
0.69~tO.04. Controls =O. il 
ocardium =0.46&0.03 , in m.ticeps surae= 
8fo.05. Myocardial lactate 115f5 
umol/g.d.w.and skeletal lactate 1 lti um0Ug.d.w. Myocardial lactate in 
controls 17.9i9.7 umol/g.d.w., n=37. 
Discussion: Despite area% suggestive of hypoperfusion all 
myocardium seemed to have a homogeneous decrease in fatty acid 
metabolism after exercise. EC extremely low both in heart and skeletal 
muscle suggesting a systemic disease and which could explain the 
fatigue. We suggest this is a new syndrome, probably due to an 
enzymatic defect e.g. aberrant Pdenylate kinase activity, with was found 
to be 5 times higher than in controls, despite unchanged isoenzyme 
patteIn. 
To assess serial changes in blood flow (MBF), oxidative metabolism 
(K, min-1) and glucose utilization (MRGLc) in myocardial segments 
identified by PET early after infarction (AMI) as infarcted or ischemic, 
10 patients were studied with PET 3.4 days (r 2-7 d, PET 1) and at 97 
days (r 70-140 d, PET 2) post-AMI. PTCA was performed in 7 
patients after PET 1. MBF was quantified with N-13 ammonia, K wirh 
C-l 1 acetate and MRGLc with F-18 deoxyglucose. Wall motion was 
determined by ZD-echo. Circumferential profile analysis of 67 anatomic 
segments identified 46 as normal, 11 as ischemic (MBF decreased, 
MRGLc preserved) and 10 as infarcted (MBF and MRGLc decreased). 
In normal myocardium, F and K con-elated with the rate pressure 
product (PET 1: r=.93 and .82, PET 2 r= .87 and .80). In normal 
segments MBF averaged .$A.25 ml/g/min, K .06+.01 min.1 and 
MRGLc .48f.21 pmol/g/min in normal myocardium and were 
unchanged at PET 2 (.753t.3 ml/g/min, .061.01 min.l..5+.25 
~mol/g/min, p=ns). In PET infarct segments, MBF (.3f. 1 ml/g/min). 
K (.03f.01 min-‘1 and MRGLc (.2f.l pmol/g/min) were markedly 
decreased and remained unchanged at PET 2 (.3+.15 /g/min, K 
.04f.015 min-l . .15&l umol/g/min, D= ns). In PET ischemic 
segments, howevkr, MBF improvid from-&O&i5 to .90&.35 ml/min/g 
(uc.05. ns vs. normal mvocardium at PET 2). K from .05+.01 to 
.&.Oi min-1, (pc.05) a.& the ratio of glucose/how normalized from 
1.8f.7 to 1.ti.l (pc.05). Wall motion improved in areas of PET 
ischemia vet remained severelv imPaired in segments with PET 
infarction.- Interestingly, 2 of lOPET infarcted seg&ents converted to 
PET ischemia after PTCA desDite unchanrred wall motion. Thus. while 
complete recovery of wall moiion was not\niformly observed at follow 
up, myocardium identified by as viable early after AM1 exhibited 
improved myocardial blood flow and oxidative metabolism and 
normalization of glucose utilization. 
11:oQ 
Juegen vom Dahl. Rodney J. Hicks. Markus 
Schwatger. Untversity of Mlchlgan. Ann Arbor, Mlchlgan. 
The quallty of F-16 FDG studies used to ident@ viable myocardlum 
may *late to metabolic factors present at the Ume of study ineludIng 
substrate availablllty. Therefore image quallty as expressed by the 
myocardlum to blood pool activity ratio (M:B) was compared to 
baseline blood glucose level (BGL) tn 35 patients (Pts) undergoing 
clinical PET FDG studies. Semi-quantitattve analysis was performed 
on static short-ax& card& &es obtained at 40 to 60 minutes after 
tracer injection. Myocardlal regions of interest were determined wlth 
the aid of N-13 ammonia perfusion studies parttcularly in patlents 
with no vtslble myocardlal FDG uptake. 
Basellne BGL r;mged from 77 to 380 mg/dl. Ten Pts had known 
dtabetes mellltus (DMI. whilst 25 Pts did not have known DM at the 
tlme of presentation. Pts without known DM at the Ume of 
presentation were grouped by baseline BGL as follows: 
tlobneax&DI 
5.7fl.6** 
lW150 (n=15) 
150-200 In=31 
lKU-D 2zh ELI 
“p<o.Ol and ‘p4l.05 compared to known DM. 
3.M. 1. 
3.1k1.5 
2.e1.2 
l&1.0 
Image quahty was lower ln Pts wtth DM than ln Pts without DM. 
There was an inverse nlattonshlp between baseltne BGL and image 
quality which may reflect competltlon of gh~cose and FDG for the 
transport and phosphorylation in the myocardial cell. Thus, 
standardlzatlon of the metabolic state is important especially if 
relative differences of regional FDG uptake are used as quantitative 
markers of tissue vtabfllty in cltnlcal PET studies. 
